Evaluation of the predictive value of the HFA-ICOS score for cardiotoxicity in breast cancer patients treated with anthracyclines and trastuzumab: a real-world observational study
Event:
Heart Failure 2025
Topic:
Cardiotoxicity of Drugs and Other Therapies
Session:
ePosters in chronic heart failure - pathophysiology and mechanisms (2)